Skip to content
Esta página está disponible en españolCambiar →

Great investors · Andreas Halvorsen · Q2 2025

What Andreas Halvorsen bought and sold in Q2 2025

Viking Global 13F portfolio as of Jun 30, 2025: 83 positions worth $34.6 bn. Largest: BAC, SCHW, COF, JPM. Filed with the SEC on Aug 14, 2025.

The 13F is filed by Viking Global, not by Andreas Halvorsen personally: these are the whole firm's positions. A “position” is a distinct security in the filing (by CUSIP); share classes of the same company are shown added together.

Buys in Q2 2025

Sells in Q2 2025

47 companies with material moves, out of 99 positions with a change. Only moves of 0.5 points of the portfolio or more are listed, measured as “traded weight” (what was bought or sold, excluding price effects). Smaller changes exist and are not listed: a position may have gone up or down without appearing above.

The full 13F, line by line

Viking Global's Q2 2025 13F lists 83 lines of US-listed securities worth $34.6 bn; the largest is BAC at 4.27% of the portfolio. It was accepted by the SEC on Aug 14, 2025 at 4:55 PM ET.

Against the previous quarter, it opened 19 positions (DIS, APD, PNC and XYZ and 15 more), closed 28 (UNH, INTU, NFLX and CB and 24 more), added to 34 (DHR, PRMB, MCD and RACE and 30 more) and trimmed 18 (USB, APG, NVDA and CVNA and 14 more). 11 lines show the same number of shares.

#CompanySharesValueWeightChange in shares
1Bank of America BAC31.2 M$1.5 bn4.27%−3%
2Charles Schwab SCHW15.8 M$1.4 bn4.16%−11%
3Capital One Financial COF5.7 M$1.2 bn3.49%+24%
4JPMorgan Chase JPM4.0 M$1.2 bn3.39%+86%
5US Bancorp \de\ USB24.1 M$1.1 bn3.15%−31%
6Taiwan Semiconductor Manufacturing TSM4.3 M$981M2.83%−11%
7McDONALD’S MCD3.1 M$913M2.64%+172%
8Amazon.com AMZN3.9 M$855M2.47%+43%
9Fortive FTV15.9 M$830M2.40%+23%
10BridgeBio Pharma BBIO18.6 M$801M2.32%−16%
11Walt Disney DIS5.8 M$725M2.10%new
12HCA Healthcare HCA1.9 M$717M2.07%+58%
13T-mobile US TMUS2.8 M$678M1.96%+82%
14BioMarin Pharmaceutical BMRN12.3 M$676M1.95%+14%
15Sherwin-williams SHW2.0 M$672M1.94%+101%
16Flutter Entertainment FLUT2.3 M$653M1.89%−11%
17General Motors GM13.0 M$641M1.85%+81%
18Philip Morris International PM3.5 M$629M1.82%+7.5%
19Cencora COR2.1 M$624M1.80%+95%
20American Tower AMT2.8 M$618M1.79%+233%
21CSX CSX18.9 M$616M1.78%+11%
22Air Products and Chemicals APD2.2 M$608M1.76%new
23Ross Stores ROST4.7 M$606M1.75%+9.9%
24Boeing BA2.8 M$594M1.72%−12%
25APi Group APG11.5 M$589M1.70%−46%
26NVIDIA NVDA3.7 M$582M1.68%−44%
27Primo Brands PRMB19.6 M$581M1.68%+290%
28Visa V1.6 M$575M1.66%−24%
29Danaher DHR2.9 M$574M1.66%+544%
30Sea SE3.5 M$566M1.64%−15%
31Qualcomm QCOM3.2 M$502M1.45%+120%
32Regal Rexnord RRX3.4 M$497M1.44%+26%
33Nike NKE7.0 M$495M1.43%+26%
34PNC Financial Services Group PNC2.4 M$443M1.28%new
35Roivant Sciences ROIV34.2 M$386M1.12%−26%
36TIC Solutions TIC34.4 M$379M1.10%no change
37First Solar FSLR2.3 M$375M1.08%+61%
38Carnival CCL13.2 M$371M1.07%+6.4%
39Block XYZ5.4 M$368M1.06%new
40D.R. Horton DHI2.8 M$364M1.05%+108%
41Carvana CVNA1.1 M$363M1.05%−58%
42Ferrari RACE721,269$354M1.02%+433%
43Tesla TSLA1.1 M$350M1.01%+214%
44Adaptive Biotechnologies ADPT30.0 M$349M1.01%no change
45Boston Scientific BSX3.0 M$327M0.95%+28%
46Eli Lilly LLY416,918$325M0.94%new
47Chipotle Mexican Grill CMG5.7 M$319M0.92%−5.3%
48Camden Property Trust CPT2.7 M$306M0.88%−2.6%
49Lennar LEN2.5 M$279M0.81%+87%
50Advanced Micro Devices AMD1.9 M$271M0.78%new
51CoStar Group CSGP3.2 M$259M0.75%new
52Ralliant RAL5.3 M$257M0.74%from a spin-off
53Arthur J. Gallagher AJG725,795$232M0.67%+8.9%
54Saia SAIA827,659$227M0.66%new
55BlackRock BLK195,104$205M0.59%new
56Meta Platforms META265,499$196M0.57%−82%
57TEVA Pharmaceutical Industries TEVA11.7 M$196M0.57%+15%
58Trade Desk TTD2.7 M$193M0.56%new
59Maplebear CART3.8 M$170M0.49%new
60CME Group CME597,374$165M0.48%new
61Integer Holdings ITGR1.3 M$158M0.46%+9.1%
62American International Group AIG1.8 M$155M0.45%new
63Johnson Controls International JCI1.5 M$153M0.44%new
64Amer Sports AS3.9 M$150M0.43%+65%
65AppLovin APP372,973$131M0.38%+172%
66Masimo MASI767,426$129M0.37%new
67NewAmsterdam Pharma NAMS7.0 M$126M0.37%no change
68RYAN Specialty Holdings RYAN1.4 M$96.1M0.28%+48%
69Royalty Pharma RPRX2.6 M$93.6M0.27%−75%
70UBS Group UBS2.6 M$87.3M0.25%new
71Molina Healthcare MOH267,421$79.7M0.23%new
72Standard Biotools LAB58.7 M$70.4M0.20%no change
73ORIC Pharmaceuticals ORIC6.6 M$66.7M0.19%no change
74Pharvaris PHVS3.7 M$64.3M0.19%no change
75Sionna Therapeutics SION3.2 M$55.4M0.16%+8.2%
76Metsera 1.6 M$46.0M0.13%no change
77Ginkgo Bioworks Holdings DNA3.6 M$40.2M0.12%no change
78Inhibrx Biosciences INBX1.8 M$25.5M0.07%no change
79Healthequity HQY219,746$23.0M0.07%new
80Establishment Labs Holdings ESTA343,465$14.7M0.04%new
81Trevi Therapeutics TRVI1.5 M$8.4M0.02%−52%
82Pepgen PEPG1.5 M$1.6M0.00%no change
83Rallybio 4.2 M$1.4M0.00%no change

Positions it closed (28)

One row per line of the filing (by CUSIP): share classes of the same company are listed separately here. “Change in shares” compares the count with the previous quarter, split-adjusted; the value is the one reported in the 13F at quarter end, not today's price.

Original documents: Viking Global's 13F filings on EDGAR (SEC) ↗

Full 13F of Viking Global: sectors and history →

Follow Andreas Halvorsen and see their Q3 2026 13F once it is filed

Free. We email you (if you turn it on) and in Following you see what each manager you follow bought and sold.

Follow Andreas Halvorsen

Source: 13F filings with the SEC. A 13F shows the portfolio at quarter-end and is filed up to 45 days later: these are not real-time positions. Not investment advice.

Follow Andreas Halvorsen for free

When the next 13F is filed, we email you (if you turn it on) and it shows in your list. No credit card.

Follow Andreas Halvorsen